» Articles » PMID: 27030211

Zyxin-Siah2-Lats2 Axis Mediates Cooperation Between Hippo and TGF-β Signalling Pathways

Overview
Journal Nat Commun
Specialty Biology
Date 2016 Apr 1
PMID 27030211
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

The evolutionarily conserved Hippo pathway is a regulator that controls organ size, cell growth and tissue homeostasis. Upstream signals of the Hippo pathway have been widely studied, but how microenvironmental factors coordinately regulate this pathway remains unclear. In this study, we identify LIM domain protein Zyxin, as a scaffold protein, that in response to hypoxia and TGF-β stimuli, forms a ternary complex with Lats2 and Siah2 and stabilizes their interaction. This interaction facilitates Lats2 ubiquitination and degradation, Yap dephosphorylation and subsequently activation. We show that Zyxin is required for TGF-β and hypoxia-induced Lats2 downregulation and deactivation of Hippo signalling in MDA-MB-231 cells. Depletion of Zyxin impairs the capability of cell migration, proliferation and tumourigenesis in a xenograft model. Zyxin is upregulated in human breast cancer and positively correlates with histological stages and metastasis. Our study demonstrates that Zyxin-Lats2-Siah2 axis may serve as a potential therapeutic target in cancer treatment.

Citing Articles

Research progress of the Hippo signaling pathway in renal cell carcinoma.

Yang Y, Gan X, Zhang W, Zhu B, Huangfu Z, Shi X Asian J Urol. 2024; 11(4):511-520.

PMID: 39534002 PMC: 11551326. DOI: 10.1016/j.ajur.2024.02.005.


Prognostic signature and immunotherapeutic relevance of Focal adhesion signaling pathway-related genes in osteosarcoma.

Wu Z, Wang Z, Hua Z, Ji Y, Ye Q, Zhang H Heliyon. 2024; 10(21):e38523.

PMID: 39524888 PMC: 11550747. DOI: 10.1016/j.heliyon.2024.e38523.


TBK1-Zyxin signaling controls tumor-associated macrophage recruitment to mitigate antitumor immunity.

Zhou R, Wang M, Li X, Liu Y, Yao Y, Wang A EMBO J. 2024; 43(21):4984-5017.

PMID: 39304793 PMC: 11535546. DOI: 10.1038/s44318-024-00244-9.


Decreased expression of p53 is associated with down expression of zyxin in breast cancer.

Rostampour R, Bahremand K, Mohammadi H, Roghani S, Shakiba E, Goodarzi M Health Sci Rep. 2024; 7(8):e2288.

PMID: 39100715 PMC: 11294437. DOI: 10.1002/hsr2.2288.


Leveraging biotin-based proximity labeling to identify cellular factors governing early alphaherpesvirus infection.

Quan J, Fan Q, Simons L, Smukowski S, Pegg C, Longnecker R mBio. 2024; 15(8):e0144524.

PMID: 38953638 PMC: 11323796. DOI: 10.1128/mbio.01445-24.


References
1.
Zhao B, Ye X, Yu J, Li L, Li W, Li S . TEAD mediates YAP-dependent gene induction and growth control. Genes Dev. 2008; 22(14):1962-71. PMC: 2492741. DOI: 10.1101/gad.1664408. View

2.
Massague J . TGFbeta in Cancer. Cell. 2008; 134(2):215-30. PMC: 3512574. DOI: 10.1016/j.cell.2008.07.001. View

3.
Mori M, Nakagami H, Koibuchi N, Miura K, Takami Y, Koriyama H . Zyxin mediates actin fiber reorganization in epithelial-mesenchymal transition and contributes to endocardial morphogenesis. Mol Biol Cell. 2009; 20(13):3115-24. PMC: 2704162. DOI: 10.1091/mbc.e09-01-0046. View

4.
Pardali K, Moustakas A . Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. Biochim Biophys Acta. 2006; 1775(1):21-62. DOI: 10.1016/j.bbcan.2006.06.004. View

5.
Saucedo L, Edgar B . Filling out the Hippo pathway. Nat Rev Mol Cell Biol. 2007; 8(8):613-21. DOI: 10.1038/nrm2221. View